These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7924433)

  • 1. Cytotoxic T cells in paramyxovirus infection of humans.
    Dhib-Jalbut S; Jacobson S
    Curr Top Microbiol Immunol; 1994; 189():109-21. PubMed ID: 7924433
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired measles-specific cytotoxic T-cell response in subacute sclerosing panencephalitis.
    Dhib-Jalbut S; Jacobson S; McFarlin DE; McFarland HF
    Ann N Y Acad Sci; 1988; 540():645-8. PubMed ID: 3264687
    [No Abstract]   [Full Text] [Related]  

  • 3. Virus-specific cytotoxic T lymphocytes in multiple sclerosis: a normal mumps virus response adds support for a distinct impairment in the measles virus response.
    Goodman AD; Jacobson S; McFarland HF
    J Neuroimmunol; 1989 May; 22(3):201-9. PubMed ID: 2467918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An immunocytochemical study on measles virus infection of the central nervous system].
    Löhler J; Bohn W
    Verh Dtsch Ges Pathol; 1981; 65():188-93. PubMed ID: 7347454
    [No Abstract]   [Full Text] [Related]  

  • 5. Virus-specific cytotoxic T cells in multiple sclerosis.
    McFarland HF; Goodman A; Jacobson S
    Ann N Y Acad Sci; 1988; 532():273-9. PubMed ID: 3263072
    [No Abstract]   [Full Text] [Related]  

  • 6. IgG1 subclass restriction of oligoclonal measles virus-specific IgG antibodies in patients with subacute sclerosing panencephalitis and in a patient with multiple sclerosis.
    Vandvik B; Natvig JB; Norrby E
    Scand J Immunol; 1977; 6(6-7):651-7. PubMed ID: 905776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between measles virus-specific antibodies and oligoclonal IgG in the cerebrospinal fluid from patients with subacute sclerosing panencephalitis and multiple sclerosis.
    Norrby E; Link H
    Acta Neurol Scand Suppl; 1977; 63():161-71. PubMed ID: 265664
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune control in experimental subacute sclerosing panencephalitis.
    Albrecht P
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):175-84. PubMed ID: 99024
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphocyte-mediated cytotoxicity to viruses in patients with multiple sclerosis: presence of a blocking factor.
    Rola-Pleszczynski M; Abernathy M; Vincent MM; Hensen SA; Bellanti JA
    Clin Immunol Immunopathol; 1976 Mar; 5(2):165-72. PubMed ID: 1084246
    [No Abstract]   [Full Text] [Related]  

  • 10. Subacute sclerosing panencephalitis: a preventable disease that needs to be prevented.
    Bale JF
    Neurology; 2004 Oct; 63(8):1352-3. PubMed ID: 15505147
    [No Abstract]   [Full Text] [Related]  

  • 11. Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein.
    Sheremata W; Sazant A; Watters G
    Can Med Assoc J; 1978 Mar; 118(5):509-13. PubMed ID: 343902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles virus-specific immunoglobulin D antibody in cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis and multiple sclerosis.
    Patrick BA; Mehta PD; Sobczyk W; Kulczycki J; Woyciechowska-Camenga J; Camenga D; Thormar H
    J Neuroimmunol; 1990 Jan; 26(1):69-74. PubMed ID: 2294143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral synthesis of antibodies to measles and distemper viruses in patients with subacute sclerosing panencephalitis and multiple sclerosis.
    Gorman NT; Habicht J; Lachmann PJ
    Clin Exp Immunol; 1980 Jan; 39(1):44-52. PubMed ID: 7389198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiopathogenetic implications of viral infections during a course of multiple sclerosis: study of cellular immunity against measles and parotitis virus].
    Smeraldi E; Bottinelli S
    Acta Neurol (Napoli); 1973; 28(3):262-7. PubMed ID: 4732486
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cellular immunity in subacute sclerosing panencephalitis and multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1975; 9(1):119-25. PubMed ID: 164635
    [No Abstract]   [Full Text] [Related]  

  • 16. Demonstration of T-cell and K-cell cytotoxicity against measles-infected cells in normal subjects, multiple sclerosis and subacute sclerosing panencephalitis.
    Ewan PW; Lachmann PJ
    Clin Exp Immunol; 1977 Oct; 30(1):22-31. PubMed ID: 304777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of hemagglutinin inhibiting antibodies of measles virus and of mumps virus and of complement fixating antibodies of respiratory syncytial viruses in a sample of the population of Riyad (Saudi Arabia)].
    Lippi M; Sebastiani A; el-Mutabakani H
    Arch Ital Sci Med Trop Parassitol; 1967; 48(5):145-52. PubMed ID: 5614889
    [No Abstract]   [Full Text] [Related]  

  • 18. Virus antibodies and multiple sclerosis.
    Sever JL; Kurtzke JF; Alter M; Schumacher GA; Gilkeson MR; Ellenberg JH; Brody JA
    Arch Neurol; 1971 Jun; 24(6):489-94. PubMed ID: 4326199
    [No Abstract]   [Full Text] [Related]  

  • 19. IgG (Gm) allotypes in acute measles encephalomyelitis and subacute sclerosing panencephalitis.
    Lebon P; Daveau M; Sesboüe R; Ponsot G; Reinert P; Salier JP
    Exp Clin Immunogenet; 1987; 4(3):125-8. PubMed ID: 3273418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Lymphocyte transformation in vitro to paramyxovirus antigens in multiple sclerosis.
    Cunningham-Rundles S; Dupont B; Posner JB; Hansen JA; Good RA
    Lancet; 1975 Dec; 2(7946):1204. PubMed ID: 53681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.